metricas
covid
Buscar en
Annals of Hepatology
Toda la web
Inicio Annals of Hepatology Risk factors contributing to early infection following transjugular intrahepatic...
Journal Information
Vol. 15. Issue 5.
Pages 752-756 (September - October 2016)
Share
Share
Download PDF
More article options
Visits
984
Vol. 15. Issue 5.
Pages 752-756 (September - October 2016)
Open Access
Risk factors contributing to early infection following transjugular intrahepatic portosystemic shunt in perioperative period
Visits
984
Peng Deng
,
Corresponding author
, Biao Zhou**, Xiao Li***
* Department of Emergency Medicine, West China Hospital, Sichuan University, Chengdu, Sichuan, China
** Institute of Interventional Radiology, West China Hospital, Sichuan University, Chengdu, Sichuan, China
*** Department of Interventional Therapy, Cancer Institute and Hospital, National Cancer Center, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, People’s Republic of China
This item has received

Under a Creative Commons license
Article information
Abstract
Full Text
Bibliography
Download PDF
Statistics
Tables (3)
Table 1. Clinical characteristics of the populations enrolled in the study.
Table 2. Blood culture results in patients with a fever > 38.5°C.
Table 3. Risk factors for bacteremia after TIPS on multivariate analysis.
Show moreShow less
Abstract

Introducción and aim. To investigate and identify the risk factors associated with early infection following a transjugular intrahepatic portosystemic shunt (TIPS)procedure in perioperative period.

Material and methods. The interventional radiology database at the West China Hospital in Sichuan, China was reviewed to identify all patients that underwent a TIPS procedure between January 30, 2013 and August 30, 2015. Four hundred and sixty-six TIPS patients with liver cirrhosis were enrolled in this study. Liver function was assessed using the Child-Pugh classification system and bacteremia was defined as patients that had a positive blood culture. Statistical analysis was performed using χ2 tests (include Fisher’s exact tests χ2) and logistic regression analyses. A P< 0.05 was set as the threshold for statistical significance.

Results. One hundred and forty-eight of the 466 (31.7%) patients developed a fever. Eighty-three of the 148 fever patients subsequently had blood drawn for cultures and 9/83 (10.8%) patients developed bacteremia as defined by a blood culture analysis. Cholangiolithiasis (P = 0.006), Child-Pugh class A designation (P = 0.001), Child-Pugh class C designation (P = 0.005) and hepatitis C virus infection (P = 0.011) were significantly correlated with fever in these patients. No statistically significant correlations were found between the other factors (age, gender, clinical manifestation, diabetes mellitus, cholangiolithiasis, etc.) and bacteremia, with the exception of periprocedure cholangiolithiasis, which was significantly correlated with blood culture-defined bacteremia (P < 0.05).

Conclusions. Cholangiolithiasis is a risk factor for infection after a TIPS procedure in the periprocedure period.

Key words:
Cholangiolithiasis
Infection
Risk factors
Transjugular intrahepatic portosystemic shunt
Full Text
Introduction and Aim

Over the past 30 years, transjugular intrahepatic portosystemic shunt (TIPS) placement has become a vital procedure in the treatment of liver cirrhosis patients complicated with portal hypertension, refractory ascites and variceal bleeding.1 Infectious complications of TIPS are uncommon but when they occur, they can be devastating.2 The TIPS procedure is performed using stent-grafts in the liver parenchyma after a tract between the hepatic and portal veins is established with a puncture needle. Despite a dramatic decrease in the morbidity and mortality associated with TIPS procedures, complications still occur. Currently, there is little data available regarding the late infectious complications after a TIPS procedure (e.g., Stent infections associated with bacteremia).3 Moreover, even less has been documented regarding the incidence of infection associated with TIPS procedures during the periprocedure period. To this end, we undertook the present study to investigate the factors associated with early infection following the TIPS procedures in the periprocedure period.

Material and MethodsSubject enrollment and data collection

The radiology database at the West China Hospital (Sichuan, China) was reviewed to identify all patients who underwent a TIPS procedure between January 30, 2013 and August 30, 2015. Stent-grafts 10 mm in diameter (Fluency Plus; Bard, Tempe, AZ, United States) were used for all procedures. Laboratory results and body temperature data were used to identify patients who developed a fever or bacteremia subsequent to the TIPS procedure. Axillary temperture > 37.3 °C was definited as fever. Bacteremia was diagnosed after two positive blood cultures were found in patients with a temperature > 38.5 °C. The following demographic and clinical data were collected from each patient: sex, age, underlying liver disease, clinical manifestation (refractory ascites or hemorrhage), and co-morbid conditions such as diabetes mellitus, cholecystolithiasis, and cholangiolithiasis. cholecystolithiasis and cholangiolithiasis was diagnosed by the upper abdominal CT 3D imagin and (or) color Doppler ultrasound, which were done to every patient before their TIPS procedure. Liver function was assessed according to the Child-Pugh classification system. Antibiotics were not administered prophylactically, since all TIPS procedures were performed electively and none of the patients had a fever prior to the TIPS procedure.

TIPS procedure

The catheter was introduced through the internal jugular vein, and guided into the hepatic vein through the superior vena cava, right atrium, and the inferior vena cava. The needle was used to puncture through the liver parenchyma and connect the intrahepatic branch of the portal vein. The balloon catheter was used to dilate the tract between the portal vein and the hepatic vein in the liver parenchyma. Finally, stent-graft(s) was inserted in the parenchymal tract.

Statistical analysis

Statistical analysis was performed using a χ2 test (include Fisher’s exact tests χ2) and logistic regression by SPSS 22.0 software (IBM Corp., Armonk, NY, United States). A P value of < 0.05 was set as the threshold for statistical significance.

Results

A total of 466 cases were reviewed and the clinical data are summarized in table 1. The patients in the case series had a mean age of 45 ± 15.3 years and included 323 males and 143 females. Two hundred and seventy-seven patients had hepatitis B virus-related cirrhosis, 21 ones had hepatitis C virus-related cirrhosis, 86 ones had alcoholic liver cirrhosis, and 96 ones had other diseases. Sixty-one patients in the cohort had diabetes mellitus, 49 ones had cholecystolithiasis and 9 of them had cholangiolithiasis. Of all the 466 patients, 148 ones developed a fever after undergoing the TIPS procedure. The stratification of patients by whether or not they had a fever in relation to the clinical characteristics is presented in table 1.

Table 1.

Clinical characteristics of the populations enrolled in the study.

CharacteristicFevernP-value*P-value**OR
Yes  No 
Sex             
Male  106  217  323  0.461     
Female  42  101  143       
Age, yr             
≥ 65  17  58  75  0.065     
< 65  131  260  391       
Clinical manifestation             
Refractory ascites  23  55  78  0.701     
Hemorrhage  123  265  388  0.701     
Concomitant disease             
Diabetes mellitus  19  42  61  0.912     
Cholecystolithiasis  14  35  49  0.612     
Cholangiolithiasis  0.006  < 0.05  7.844 
Child-Pugh class             
42  141  183  0.001  < 0.05  0.497 
81  151  232  0.145     
25  26  51  0.005  < 0.05  2.283 
Underlying liver disease             
PBC  11  17  28  0.378     
HBV  86  191  277  0.689     
HCV  12  21  0.011  < 0.05  3.029 
AIH  0.238     
ALC  23  63  86  0.269     
BCS  10  18  0.238     
Schistosome  0.271     
Unknown  28  34  0.065     
*

The χ2 test.

**

Logistic regression. AIH: autoimmune hepatitis. OR: Odds ratio. ALC: alcoholic liver cirrhosis. BCS: Budd-Chiari syndrome. HBV: hepatitis B virus. HCV: hepatitis C virus. PBC: primary biliary cirrhosis.

Out of the 148 patients that had a fever, 65 had a fever < 38.5°C and were thus not tested for bacteremia. In 58 of these patients, the fever was attributed to aseptic necrosis of material absorption and these patients recovered without antibiotics. The remaining 7/65 patients received antibiotics, as their fever was due to unknown origin. All the eighty-three patients who had a fever > 38.5°C had blood drawn twice for cultures, and 9/83 patients (seven male, two female; median age: 46.5 years; range: 39-60 years) had bacteremia as defined by a positive blood culture. Bacteremia onset occurred a median of 2.5 d (range: 1-5 d) after the TIPS procedure was performed. The bacteremia resolved in 7/9 patients within a median of 7 d after antibiotics were initiated. The remaining two patients died due to an infection of the bile duct. From the blood culture analysis, three bacteremia patients tested positive for Escherichia coli, while the remaining four patients tested positive for Aeromonashydrophila, Gemellamorbillorum, Burkholderiacepacia, Citrobacter freundii, Klebsiella pneumoniae subsp Pneumoniae and Streptococcus cristatus (S. cristatus) (Table 2). It was also suspected that one of the cholangiolithiasis patients had bacteremia due to a high body temperature and elevated procalcitonin levels. This patient was not included in our bacteremia numbers, as the blood culture did not come back positive. Cholangiolithiasis, Child-Pugh class A designation, Child-Pugh class C designation and hepatitis C virus infection were significantly correlated with fever. Only the Child-Pugh class A designation was negatively correlated with infection after χ2 test (OR: 0.497). With the exception of cholangiolithiasis, which was significantly associated with blood culture-defined bacteremia (P = 0.025), no statistical correlation between the other characteristics and bacteremia was observed (Table 3).

Table 2.

Blood culture results in patients with a fever > 38.5°C.

Patient  Liver disease  CP class  Antibiotic Px  Days after TIPS  Organism  Concomitant disease 
HBV related  No  Streptococcus cristatus  Cholangiolithiasis 
Alcohol related  No  Escherichia coli  Cholangiolithiasis 
HBV related  No  Escherichia coli  Cholangiolithiasis 
HBV related  No  Escherichia coli  None 
HCV related  No  Burkholderiacepacia  None 
HBV related  No  Gemellamorbillorum  None 
HBV related  No  Aeromonashydrophila  None 
HBV related  No  Citrobacter freundii  None 
PBC related  No  Klebsiella pneumoniae subsp pneumoniae  Diabetes mellitus 

CP: Child-Pugh. HBV: hepatitis B virus. HCV: hepatitis C virus. Px: prophylaxis. TIPS: transjugular intrahepatic portosystemic shunt. PBC: primary biliary cirrhosis.

Table 3.

Risk factors for bacteremia after TIPS on multivariate analysis.

CulturenP-value*OR
Positive  Negative 
Hepatitis C virus        0.509   
Yes     
No  69  77     
Cholangiolithiasis        0.025  8.750 
Yes     
No  70  76     
Child-Pugh class C        0.065   
Yes  12  16     
No  62  67     
*

The χ2 test (Fisher’s exact tests).

Conclusions

Over the past few years, TIPS placement has become a universally accepted method in the management of complications associated with portal hypertension, and variceal bleeding in particular. TIPS placement is a minimally invasive technique that reduces portal venous pressure without the requirement of a surgical laparotomy and its associated complications. Patients with impaired liver function or cirrhosis frequently develop bacterial infections, which causes death in 30%-50% of cases.4,5 Infectious complications resulting from TIPS placement, however, have been reported infrequently. One case series documented fever following the TIPS procedure in 10%-35% of patients; sustained bacteremia was rare, however, with an estimated annual incidence of 7/1000 cases post-TIPS.6,7 In our study, 148/466 (31.7%) patients developed a fever, 83/148 (56.0%) patients had blood drawn for cultures, and 9/83 (10.8%) developed blood culture-confirmed bacteremia.

Of all the factors investigated in our study, only cholan-giolithiasis, Child-Pugh class A designation, Child-Pugh class C designation and hepatitis C virus infection were significantly correlated with fever. The Child-Pugh A classification was the only factor negatively correlated with infection. Because decompensated liver cirrhosis is a contraindication of interferon therapy, patients with hepatitis C viral infections and liver cirrhosis were difficult to treat and were more susceptible to infection.

In our analysis, only cholangiolithiasis was significantly associated with bacteremia. Although intrahepatic stenting may cause liver inflammation, an inflammatory response initiated by translocation of intestinal bacteria more likely accounts for the bacteremia.6,7 The pathophysiologic role of bacteria in the formation of gallstones was proposed many years ago. In Western countries, gallstones are predominantly composed of cholesterol, and bacteria do not play a significant role in the pathogenesis.8 Bacterial infections of the bile duct, however, may play a critical role in the development of “brown-pigment” gallstones, which are composed primarily of bilirubin. Bacteria are often found in high concentrations in brown-pigment gallstones and less frequently in cholesterol gallstones.9 The brown-pigment stones may provide an environment conducive to bacterial infection in some cases.1014 Other studies have instead suggested that the bacteria play a role in the formation of gallstones, which often co-present in patients with juxtapapillary duodenal diverticula.15 Thus, there may be an increase in bacteria in the bile duct in cholan-giolithiasis patients, who may be more susceptible to infection. Similar to what has been published previously, our study found that the majority of infection cases were due to enteric bacteria.7,16 In our study, blood culture results for 3/9 patients with cholangiolithiasis were positive, with two patients positive for E. coli and one patient positive for S. cristatus. During the TIPS procedure, the needle is punctured through the parenchyma between the portal vein and hepatic veins, which we hypothesize may injure the enlarged bile duct and cause the release of bacteria into the blood stream. Bacteremia may also be caused by translocation of the bile stone itself, which leads to bile duct obstruction and subsequent infection. Despite the widespread use of antimicrobial prophylaxis, it was not administered in our study. Although studies evaluating antibiotic prophylaxis for TIPS procedures have yielded conflicting results and a one-time dose of ceftriaxone (1 or 2 g) has been shown to reduce the rate of post-TIPS infection.17 The most common agents used are third generation cephalosporins, though it has been noted that they provide inadequate coverage against Enterococcus faecalis, one of the most commonly implicated organisms.18 In our study, cholangiolithiasis may determine whether antibiotics should be administered prophylactically during the periprocedure period following a TIPS procedure.

In the present study, bile cultures were not performed. Grill, et al.19 suggested that the detection of bacteria in bile cultures is influenced by the toxicity of bile salts. Therefore, traditional bile culture methods may overlook a significant number of underlying bacterial infections.1922

There are a few limitations to the present study. One limitation is that blood culture was only done to those patients with a fever > 38.5°C, though some patients with a fever < 38.5°C may have also had bacteremia. A second limitation was that this case series did not include a control group of cirrhotic patients that did not undergo a TIPS procedure. In the present study, we identified periprocedure cholangiolithiasis as a potential risk factor for infection following TIPS procedures. Further research is warranted to better define infectious risk factors before and after TIPS procedures.

Abbreviations

  • TIPS: transjugular intrahepatic portosystemic shunt.

Financial Support

No financial support.

Acknowledgements

The authors wish to acknowledge the West China Hospital for excellent technical support.

References
[1.]
Rösch J., Hanafee W.N., Snow H..
Transjugular portal venography and radiologic portacaval shunt: an experimental study.
Radiology, 92 (1969), pp. 1112-1114
[2.]
Halpenny D.F., Torreggiani W.C..
The infectious complications of interventional radiology based procedures in gastroenterology and hepatology.
J Gastrointestin Liver Dis, 20 (2011), pp. 71-75
[3.]
Schiano T.D., Atillasoy E., Fiel M.I., Wolf D.C., Jaffe D., Cooper J.M., Jonas M.E., et al.
Fatal fungemia resulting from an infected transjugular intrahepatic portosystemic shunt stent.
Am J Gastroenterol, 92 (1997), pp. 709-710
[4.]
Borzio M., Salerno F., Piantoni L., Cazzaniga M., Angeli P., Bissoli F., Boccia S., et al.
Bacterial infection in patients with advanced cirrhosis: a multicentre prospective study.
Dig Liver Dis, 33 (2001), pp. 41-48
[5.]
Fernández J., Navasa M., Gómez J., Colmenero J., Vila J., Arroyo V., Rodés J..
Bacterial infections in cirrhosis: epidemiological changes with invasive procedures and norfloxacin prophylaxis.
Hepatology, 35 (2002), pp. 140-148
[6.]
Freedman A.M., Sanyal A.J., Tisnado J., Cole P.E., Shiffman M.L., Luketic V.A., Purdum P.P., et al.
Complications of transjugular intrahepatic portosystemic shunt: a comprehensive review.
Radiographics, 13 (1993), pp. 1185-1210
[7.]
DeSimone J.A., Beavis K.G., Eschelman D.J., Henning K.J..
Sustained bacteremia associated with transjugular intrahepatic portosystemic shunt (TIPS).
Clin Infect Dis, 30 (2000), pp. 384-386
[8.]
Cotran R, Kumar V, Collins T, Robbins S, Schmitt B. Robbins’ Pathologic Basis of Disease. 6th ed. Boston: WB Saunders; 1999, pp. 454-78.
[9.]
Manolis E.N., Filippou D.K., Papadopoulos V.P., Kaklamanos I., Katostaras T., Christianakis E., Bonatsos G., et al.
The culture site of the gallbladder affects recovery of bacteria in symptomatic cholelithiasis.
J Gastrointestin Liver Dis, 17 (2008), pp. 179-182
[10.]
Chang W.T., Lee K.T., Wang S.R., Chuang S.C., Kuo K.K., Chen J.S., Sheen P.C..
Bacteriology and antimicrobial susceptibility in biliary tract disease: an audit of 10-year’s experience.
Kaohsiung J Med Sci, 18 (2002), pp. 221-228
[11.]
Swidsinski A., Lee S.P..
The role of bacteria in gallstone pathogenesis.
Front Biosci, 6 (2001), pp. E93-103
[12.]
Kawai M., Iwahashi M., Uchiyama K., Ochiai M., Tanimura H., Yamaue H..
Gram-positive cocci are associated with the formation of completely pure cholesterol stones.
Am J Gastroenterol, 97 (2002), pp. 83-88
[13.]
Al Harbi M., Osoba A.O., Mowallad A., Al-Ahmadi K..
Tract microflora in Saudi patients with cholelithiasis.
Trop Med Int Health, 6 (2001), pp. 570-574
[14.]
Csendes A., Mitru N., Maluenda F., Diaz J.C., Burdiles P., Csendes P., Pinones E..
Counts of bacteria and pyocites of choledochal bile in controls and in patients with gallstones or common bile duct stones with or without acute cholangitis.
Hepatogastroenterology, 43 (1996), pp. 800-806
[15.]
Lötveit T., Osnes M., Aune S..
Bacteriological studies of common duct bile in patients with gallstone disease and juxtapapillary duodenal diverticula.
Scand J Gastroenterol, 13 (1978), pp. 93-95
[16.]
Sanyal A.J., Reddy K.R..
Vegetative infection of transjugular intrahepatic portosystemic shunts.
Gastroenterology, 115 (1998), pp. 110-115
[17.]
Gulberg V., Deibert P., Ochs A., Rossle M., Gerbes A.L..
Prevention of infectious complications after transjugular intrahepatic portosystemic shunt in cirrhotic patients with a single dose of ceftriaxone.
Hepatogastroenterology, 46 (1999), pp. 1126-1130
[18.]
Ryan J.M., Ryan B.M., Smith T.P..
Antibiotic prophylaxis in interventional radiology.
J VascInterv Radiol, 15 (2004), pp. 547-556
[19.]
Grill J.P., Perrin S., Schneider F..
Bile salt toxicity to some bifidobacteria strains: role of conjugated bile salt hydrolase and pH.
Can J Microbiol, 46 (2000), pp. 878-884
[20.]
Cheng H.Y., Yang H.Y., Chou C.C..
Influence of acid adaptation on the tolerance of Escherichia coli O157: H7 to some subsequent stresses.
J Food Prot, 65 (2002), pp. 260-265
[21.]
De Boever P.W..
Bile salt deconjugation by lactobacillus plantarum 80 and its implication for bacterial toxicity.
J ApplMicrobiol, 87 (1999), pp. 345-352
[22.]
Kurtin W.E., Enz J., Dunsmoor C., Evans N., Lightner D.A..
Acid dissociation constants of bilirubin and related carboxylic acid compounds in bile salt solutions.
Arch Biochem Biophys, 381 (2000), pp. 83-91
Copyright © 2016. Fundación Clínica Médica Sur, A.C.
Download PDF
Article options
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos

Quizás le interese:
10.1016/j.aohep.2022.100713
No mostrar más